Mitochondrial function and morphology are impaired in <i>parkin</i>‐mutant fibroblasts

Abstract

Our study demonstrates marked abnormalities of mitochondrial function and morphology in parkin-mutant patients and provides proof-of-principle data for the potential usefulness of this new model system as a tool to screen for disease-modifying compounds in genetically homogenous parkinsonian disorders.